ACXP Archived Articles
Acurx Pharmaceuticals (ACXP): A Late-Stage Biopharma Tackling Antimicrobial Resistance
Published on November 30, 2024
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP): A Promising Antibiotic Candidate Targeting a Billion-Dollar Market
Published on September 24, 2024